» Articles » PMID: 35118411

Nonhormonal Therapy for Endometriosis Based on Energy Metabolism Regulation

Overview
Journal Reprod Fertil
Date 2022 Feb 4
PMID 35118411
Authors
Affiliations
Soon will be listed here.
Abstract

Lay Summary: The most commonly used medical therapies for endometriosis have contraceptives and other side effects associated with hormone suppression and are therefore unsuitable for women desiring pregnancy. One therapeutic strategy that may avoid hormone manipulation is focused on changing metabolic profiles that have been detected in cells/tissues from women with endometriosis. Endometriotic cells favor glycolytic metabolism over mitochondrial oxidative phosphorylation (OXPHOS) to produce essential energy for cell growth. Furthermore, the metabolic conversion from mitochondrial OXPHOS to aerobic glycolysis suppresses cell death through the reduced generation of reactive oxygen species (ROS). This unique metabolic feature of endometriosis is important for cell survival and disease progression. Thus, changing the specific metabolic switch may increase mitochondrial ROS production, causing severe oxidative stress and cell death. This review describes new treatments by changing the metabolic profiles of endometriosis.

Citing Articles

Association between triglyceride-glucose index and endometriosis: results from a cross-sectional study and Mendelian randomization study.

Xu T, Zhuang Y, Cao H, Yang J Front Endocrinol (Lausanne). 2025; 15():1388570.

PMID: 39850480 PMC: 11753958. DOI: 10.3389/fendo.2024.1388570.


Non-Hormonal Therapy for Endometriosis Based on Angiogenesis, Oxidative Stress and Inflammation.

Sanamiri K, Mahdian S, Moini A, Shahhoseini M Int J Fertil Steril. 2024; 18(4):305-313.

PMID: 39564820 PMC: 11589980. DOI: 10.22074/ijfs.2024.2012554.1547.


Endometriotic lesions exhibit distinct metabolic signature compared to paired eutopic endometrium at the single-cell level.

Sarsenova M, Lawarde A, Pathare A, Saare M, Modhukur V, Soplepmann P Commun Biol. 2024; 7(1):1026.

PMID: 39169201 PMC: 11339455. DOI: 10.1038/s42003-024-06713-5.


Altered Monocyte and Lymphocyte Phenotypes Associated with Pathogenesis and Clinical Efficacy of Progestogen Therapy for Peritoneal Endometriosis in Adolescents.

Khashchenko E, Krechetova L, Vishnyakova P, Fatkhudinov T, Inviyaeva E, Vtorushina V Cells. 2024; 13(14.

PMID: 39056769 PMC: 11274988. DOI: 10.3390/cells13141187.


Follicular Fluid and Blood Monitorization of Infertility Biomarkers in Women with Endometriosis.

Brinca A, Peiro A, Evangelio P, Eleno I, Oliani A, Silva V Int J Mol Sci. 2024; 25(13).

PMID: 39000283 PMC: 11241429. DOI: 10.3390/ijms25137177.


References
1.
Ferrero S, Evangelisti G, Barra F . Current and emerging treatment options for endometriosis. Expert Opin Pharmacother. 2018; 19(10):1109-1125. DOI: 10.1080/14656566.2018.1494154. View

2.
Leow H, Koscielniak M, Williams L, Saunders P, Daniels J, Doust A . Dichloroacetate as a possible treatment for endometriosis-associated pain: a single-arm open-label exploratory clinical trial (EPiC). Pilot Feasibility Stud. 2021; 7(1):67. PMC: 7953373. DOI: 10.1186/s40814-021-00797-0. View

3.
Miao P, Sheng S, Sun X, Liu J, Huang G . Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB Life. 2013; 65(11):904-10. DOI: 10.1002/iub.1216. View

4.
Hirschhaeuser F, Sattler U, Mueller-Klieser W . Lactate: a metabolic key player in cancer. Cancer Res. 2011; 71(22):6921-5. DOI: 10.1158/0008-5472.CAN-11-1457. View

5.
Halestrap A . The monocarboxylate transporter family--Structure and functional characterization. IUBMB Life. 2011; 64(1):1-9. DOI: 10.1002/iub.573. View